Total Clarity Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Buy |
1,262
+50
| +4% | +$22.3K | 0.16% | 145 |
|
|
2025
Q1 | $488K | Sell |
1,212
-25
| -2% | -$10.1K | 0.16% | 150 |
|
|
2024
Q4 | $498K | Sell |
1,237
-12
| -1% | -$4.83K | 0.16% | 151 |
|
|
2024
Q3 | $581K | Hold |
1,249
| – | – | 0.19% | 133 |
|
|
2024
Q2 | $585K | Sell |
1,249
-78
| -6% | -$36.6K | 0.2% | 121 |
|
|
2024
Q1 | $555K | Buy |
1,327
+55
| +4% | +$23K | 0.19% | 137 |
|
|
2023
Q4 | $518K | Sell |
1,272
-20
| -2% | -$8.14K | 0.21% | 123 |
|
|
2023
Q3 | $449K | Buy |
1,292
+25
| +2% | +$8.69K | 0.22% | 122 |
|
|
2023
Q2 | $446K | Buy |
1,267
+27
| +2% | +$9.5K | 0.22% | 115 |
|
|
2023
Q1 | $391K | Sell |
1,240
-25
| -2% | -$7.88K | 0.21% | 112 |
|
|
2022
Q4 | $365K | Sell |
1,265
-15
| -1% | -$4.33K | 0.19% | 136 |
|
|
2022
Q3 | $371K | Hold |
1,280
| – | – | 0.23% | 131 |
|
|
2022
Q2 | $361K | Sell |
1,280
-145
| -10% | -$40.9K | 0.19% | 132 |
|
|
2022
Q1 | $372K | Sell |
1,425
-15
| -1% | -$3.92K | 0.2% | 135 |
|
|
2021
Q4 | $316K | Sell |
1,440
-40
| -3% | -$8.78K | 0.14% | 153 |
|
|
2021
Q3 | $268K | Buy |
+1,480
| New | +$268K | 0.13% | 178 |
|